AI-Designed Cancer Drug Shows 78% Tumor Reduction in Phase 2 Trials
The molecule was designed entirely by AI in 18 months instead of the typical 5 years. Phase 3 trials begin next month.
Pharma - Latest News & Analysis
In-depth coverage, analysis, and updates on Pharma in AI and tech. 2 articles on AI Pulse.
AI Is Rewriting Drug Discovery—And Big Pharma Is Scrambling
The first AI-designed drugs are in Phase 3 trials. The old way of making medicine is dying.